Fidson Healthcare Plc, a top pharmaceutical company in Nigeria, has appointed three new directors in a move to bolster its team’s strategy.
The decision was reached by the board in December, 2024, according to an official statement released on Wednesday.
Babatunde Kabir Ipaye, Philip Ikechi Ejiofor and Oshoke Michael Ayebae came into effect from January 1, 2025.
The company aims to enhance its governance, driving sustainable growth and business expansion initiatives through the diverse experience of these accomplished professionals.
Babatunde Kabir Ipaye joins the board as an independent non-executive director. The distinguished governance and public health specialist brings over two decades of experience in leadership, policy development, and health systems reform.
Read also: Fidson Healthcare moves to tackle Nigeria’s medical challenges with new partnership
With a medical degree earned from the University of Lagos as the overall best graduate of his class and multiple national and international consulting roles, he has contributed significantly to public health initiatives, including malaria, tuberculosis, HIV/AIDS, and COVID-19 programmes in Nigeria and beyond.
Ipaye has held esteemed positions, such as commissioner for Health in Ogun State and consultant health specialist with the World Bank, where he demonstrated exceptional capacity in healthcare delivery and policy implementation.
His vast expertise is expected to enhance Fidson’s strategic focus and operational impact in the healthcare sector.
Philip Ikechi Ejiofor also joins the board as an independent non-executive director. He is a chartered accountant with over 30 years of senior management experience, spanning finance, logistics, supply chain, and information technology. His extensive international experience, encompassing leadership roles in various multinational organizations in Nigeria and Rwanda, has honed his skills in strategic financial planning, regulatory compliance, and organizational development.
Ejiofor’s proven ability to drive operational efficiency and mentor high-performing teams aligns seamlessly with Fidson’s vision of excellence and innovative leadership.
Oshoke Michael Ayebae has been appointed executive director, Business Development and Marketing. Since joining Fidson Healthcare Plc in 2011, Ayebae has demonstrated remarkable leadership, establishing the company’s herbal and nutraceutical division and later spearheading its business development function since 2016, where he led the development of over 40 new profitable products in 5 years and rebranded over 80 percent of Fidson’s product portfolio for better shelf presence and brand acceptance. With degrees in Marketing and Business Management from Bradford University and a Master’s in Programme and Project Management from the University of Warwick, his contributions have driven significant growth and brand visibility for the company.
Read also: Fidson Healthcare to raise N20bn additional capital
Speaking on the appointments, Olusegun Adebanji, chairman of the Board, stated that “We are pleased to welcome these accomplished professionals to the board. Their wealth of experience and strategic insights will strengthen our board’s capacity to deliver on our mission.”
Fidson Healthcare Plc contributions to healthcare delivery in Nigeria has received several recognitions including the Pharmaceutical Manufacturing Company of the Year by the Nigeria Healthcare Excellence Awards and one of Africa’s Fastest Growing Companies by The Financial Times, London.
The company remains dedicated to advancing healthcare in Africa, leveraging the expertise of its board members and the commitment of its workforce to achieve sustainable growth and industry leadership.
Join BusinessDay whatsapp Channel, to stay up to date
Open In Whatsapp
